ArticleQuantitative imaging in medicine and surgery2024
Progressive changes in non-neoplastic ground-glass nodules on follow-up computed tomography (CT).
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlation between CT growth patterns and invasiveness progression in neoplastic subcentimeter sub-solid nodules.Annals of medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-neoplastic ground-glass nodules (GGNs) generally decrease in size or density during follow-up; however, some exhibit the opposite effect (and show progressive changes), which can lead to unnecessary resection. This study sought to determine the progressive changes in non-neoplastic GGNs using follow-up computed tomography (CT). Methods: This cross-sectional study included 70 patients diagnosed with pathologically confirmed non-neoplastic GGNs from January 2017 to March 2023. Of the patients, 35 showed progressive changes and 35 showed no significant changes. The initial and preoperative chest CT images were reviewed to evaluate their changes. The progressive changes in the GGNs were classified into the following five types: type I: increasing density; type II: increasing size; type III: increasing density and solid component; type IV: increasing size and density/solid component; and type V: increasing size, density, and solid component. The T-test, Pearson chi-square test, Wilkinson sign test and Mann-Whitney U-test were used for the data analysis. A two-sided P value <0.05 was considered statistically significant. Results: Among the 35 GGNs with progressive changes, type II (14, 40.0%) was the most common, followed by types IV (9, 25.7%), I (5, 14.3%), V (5, 14.3%), and III (2, 5.3%). The number of lesions that changed in <6, ≥6 and <12, ≥12 and ≤24, >24 months was 22 (62.9%), 4 (11.4%), 5 (14.3%), and 4 (11.4%), respectively. Among the 28 GGNs with an increasing volume, the number of lesions with a volume doubling time (VDT) of <344 and >441 days was 20 (71.4%) and 8 (28.6%), respectively. Except for these progressive changes, the other features did not exhibit significant changes, especially the ill-defined boundary (74.3% Conclusions: GGNs with progressive changes are more likely to be non-neoplastic if the changes occur in a short period or the lesions maintain an ill-defined boundary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.